Avidity Biosciences
RNAM
#1867
Rank
A$16.05 B
Marketcap
A$103.92
Share price
0.00%
Change (1 day)
129.99%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$16.05 Billion

As of June 2026 Avidity Biosciences has a market cap of A$16.05 Billion. This makes Avidity Biosciences the world's 1867th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$16.05 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$205.04 B 1,177.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.90 B 802.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.64 B-83.55%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$9.34 B-41.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.34 B-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.17 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.60 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.48 B-65.86%๐Ÿ‡บ๐Ÿ‡ธ USA